The study
Mayo Clinic researchers have validated an AI model that detects pancreatic cancer early. The model can spot signs of the disease up to three years before diagnosis. The findings come from a landmark validation study announced by the Mayo Clinic News Network.
Pancreatic cancer is one of the deadliest forms of cancer. It often shows no symptoms until it has spread. Most patients are diagnosed too late for surgery. Early detection could change those odds.
How the AI works
The model analyzes electronic health records. It looks for patterns in lab results, medical history, and symptoms. Small changes can signal that a patient is at risk. The system flags those patients for further testing.
In the study, the model identified at-risk patients with high accuracy. It caught signals years before a formal diagnosis. The tool is designed to work alongside doctors, not replace them. Clinicians review the alerts and decide on next steps.
Why early detection matters
Survival rates for pancreatic cancer are low. Only about one in ten patients lives five years after diagnosis. When the cancer is caught early, that rate improves sharply. Surgery becomes possible and treatments work better.
Researchers say the AI tool could be used in routine care. Doctors could screen high-risk patients automatically. The next step is a clinical trial to test the model in practice. If successful, the tool could help save thousands of lives each year.